Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs VivioMD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and VivioMD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 449 · Grade C

VivioMD

Visit VivioMD Full brief →

FDA warning letter, June 2026 — issued to VivioMD Group LLC dba VivioMD. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 55 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make VivioMD a bad call — it's best for readers comparing injection and tablet options who can confirm the formulation and next billing date. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
40
Supply Reliability
95
73
Transparency
90
23
Access Breadth
93
70
Clinical Oversight
92
80
Track Record
88
52
CoreAge RxBrief Score 94 · 55VivioMD

Price, coverage & the tracker

CoreAge RxVivioMD
Brief Score94/100 (A)55/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

GLP-1 tablets and injections are listed. Ozempic has a separate price.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

GLP-1/GIP injections are listed. Confirm the active ingredient and charge.

CoverageUS only; restrictions by state, confirmed at intakeVivioMD advertises a nationwide clinician network. Confirm dispensing for your address.
Brand-name accessNot confirmedVivioMD separately lists Ozempic.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

VivioMD: Check the selected formulation and give notice before renewal.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.